Axial Therapeutics
Axial Therapeutics is a biopharmaceutical company targeting neurological disorders such as Parkinson's and Autism via gut health.
6
Funding Rounds
$116.0m
Money raised
Overview
Axial Therapeutics is a biopharmaceutical company targeting neurological disorders such as Parkinson's and Autism via gut health.
-
Website:
- Business model: B2C B2B
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Mi* Di** | - | - | |
| Da*** H Do*** |
|
- | - |
| Je E. Yo*** | - | - |
Funding series
Funding Series Analysis
The company Axial Therapeutics has raised a total of $37.25m in funding over 6 rounds.
Key Insights:
- Axial Biotherapeutics Series C round, October 13, 2021: $37.25m
- Axial Biotherapeutics funding round, June 2019: $10m
- Axial Biotherapeutics Venture round, June 2019: $5m
- Axial Biotherapeutics Series B round, February 2019: $25m
- Axial Biotherapeutics Series A round, November 2016: $19.5m
- Axial Biotherapeutics Series A round, December 2016: $19.2m
Axial Biotherapeutics Series C round, October 13, 2021
$37.25m
Axial Biotherapeutics funding round, June 2019
$10m
Axial Biotherapeutics Venture round, June 2019
$5m
Axial Biotherapeutics Series B round, February 2019
$25m
Axial Biotherapeutics Series A round, November 2016
$19.5m
Axial Biotherapeutics Series A round, December 2016
$19.2m
Industries
Axial Therapeutics is active in the following industries: